Brodin Ellen, Iversen Nina, Hansen John-Bjarne
Center for Atherothrombotic Research in Tromsø (CART), Department of Medicine, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway.
J Lab Clin Med. 2006 Apr;147(4):167-73. doi: 10.1016/j.lab.2005.11.010.
Tissue factor pathway inhibitor (TFPI) is a potent inhibitor of tissue factor (TF)-induced blood coagulation. A positive association between very low density lipoproteins (VLDLs) and TFPI has been reported in vivo. In contrast, one in vitro study indicates that TFPI may enhance lipoprotein lipase (LPL) activity, thereby increasing triglyceride hydrolysis. The current study was conducted to investigate how native VLDL influenced the synthesis and release of TFPI in endothelial cells, and how TFPI affected the LPL-induced hydrolysis of VLDL in vitro and at the endothelial surface. A spontaneously transformed immortal endothelial cell line (ECV304) and primary coronary artery cells (CoEc) were used, and VLDL was isolated from healthy volunteers by density gradient ultracentrifugation. Sequential free fatty acid (FFA) measurements were used to evaluate the kinetics of the LPL-induced hydrolysis. The levels of TFPI mRNAs in the stimulated cells were determined by quantitative real-time reverse transcription-ploymerase chain reaction (qPCR) using the ABI PRISM 7700 Sequence Detection System. Stimulation of ECV304 cells for 24 hours with native VLDL (0-100 microg/mL) caused a dose-dependent increase of TFPI in the medium (6.7-23.8 ng/10(6) cells, P < 0.001), without affecting the cellular content of TFPI. The expression of TFPI mRNA was significantly upregulated after 10 minutes of stimulation with n-VLDL. Both recombinant TFPI (r-TFPI) and LPL showed a dose-dependent binding to ECV 304 cells without saturation, and no competitive binding interactions between LPL and TFPI were observed at the endothelial surface. The addition of increasing concentrations of r-TFPI to ECV 304 cells, preincubated with LPL, did not affect the hydrolysis of VLDL triglycerides. The maximal reaction velocity (V(max)) of LPL-induced hydrolysis of n-VLDL was not affected by the addition of increasing concentrations of r-TFPI to the reaction mixture in vitro. The current experimental study indicates an upregulation of TFPI synthesis and release by VLDL. LPL-induced hydrolysis of VLDL in vitro was not influenced by TFPI neither in suspension nor at the endothelial surface.
组织因子途径抑制剂(TFPI)是组织因子(TF)诱导的血液凝固的有效抑制剂。体内研究报道极低密度脂蛋白(VLDL)与TFPI之间存在正相关。相比之下,一项体外研究表明TFPI可能增强脂蛋白脂肪酶(LPL)的活性,从而增加甘油三酯的水解。本研究旨在探讨天然VLDL如何影响内皮细胞中TFPI的合成和释放,以及TFPI如何在体外和内皮表面影响LPL诱导的VLDL水解。使用自发转化的永生化内皮细胞系(ECV304)和原代冠状动脉细胞(CoEc),通过密度梯度超速离心从健康志愿者中分离VLDL。采用连续游离脂肪酸(FFA)测量来评估LPL诱导水解的动力学。使用ABI PRISM 7700序列检测系统,通过定量实时逆转录 - 聚合酶链反应(qPCR)测定刺激细胞中TFPI mRNA的水平。用天然VLDL(0 - 100μg/mL)刺激ECV304细胞24小时导致培养基中TFPI呈剂量依赖性增加(6.7 - 23.8 ng/10⁶细胞,P < 0.001),而不影响细胞内TFPI的含量。用n - VLDL刺激10分钟后,TFPI mRNA的表达显著上调。重组TFPI(r - TFPI)和LPL均显示与ECV 304细胞呈剂量依赖性结合且无饱和现象,在内皮表面未观察到LPL与TFPI之间的竞争性结合相互作用。向预先与LPL孵育的ECV 304细胞中添加浓度递增的r - TFPI,不影响VLDL甘油三酯的水解。在体外反应混合物中添加浓度递增的r - TFPI,不影响LPL诱导的n - VLDL水解的最大反应速度(Vmax)。当前的实验研究表明VLDL可上调TFPI的合成和释放。TFPI在体外悬浮状态下或在内皮表面均不影响LPL诱导的VLDL水解。